As of September 2024, Nextgen Biomed has a market cap of $1.63M. This makes Nextgen Biomed the world's 36390th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.27M | -10.14% |
2023 | $2.53M | 102.87% |
2022 | $1.25M | -55.05% |
2021 | $2.77M | -41.88% |
2020 | $4.77M | 90466.04% |
2019 | $5.27K | -9.56% |
2018 | $5.83K | -0.34% |
2017 | $5.85K | 53.13% |
2016 | $3.82K | -57.62% |
2015 | $9.01K | -91.87% |
2014 | $110.82K | 67.47% |
2013 | $66.17K | -92.10% |
2012 | $837.13K | 388.37% |
2011 | $171.41K | -66.67% |
2010 | $514.24K | -70.50% |
2007 | $1.74M | -26.47% |
2006 | $2.37M | -2.67% |
2005 | $2.44M | 5.79% |
2004 | $2.30M | 97.21% |
2003 | $1.17M | 41.90% |
2002 | $822.71K | - |